691
Views
13
CrossRef citations to date
0
Altmetric
Clinical Focus: Cardiovascular Disease - Original Research

Increasing use of CTPA for the investigation of suspected pulmonary embolism

&
Pages 193-197 | Received 31 Oct 2016, Accepted 09 Jan 2017, Published online: 20 Jan 2017
 

ABSTRACT

Objectives: Pulmonary embolism (PE) is a frequently suspected life-threatening condition that often presents with non-specific signs and symptoms. There is concern that increased availability of computerized tomography pulmonary angiogram (CTPA) is resulting in overuse in the diagnostic workup of patients presenting with cardio-respiratory symptoms. We therefore aimed to determine whether use of CTPA was increasing over time within our institution, with a consequent decrease in the diagnostic yield of PE. Furthermore, we investigated the frequency of alternative (non-PE) pathological findings revealed by CTPA.

Methods: All patients who underwent CTPA in the first 15 days of eight consecutive years were enrolled retrospectively. Radiology reports and online medical records were examined. In addition, the rates of incidental PE from patients undergoing CT chest for non-suspected PE indications were also examined.

Results: An increasing use of CTPA was confirmed (p = 0.04). Despite this, the diagnostic yield of PE also increased (p = 0.03). Similarly, increasing numbers of patients underwent CT chest for non-PE indications, but in this group the rate of incidental PE remained static (~3.4%). In CPTA investigations that were negative for PE, common alternative findings were consolidation, pleural effusion and emphysema, with only 16.7% showing no abnormality.

Conclusion: Although CTPA use is increasing, so is the diagnostic yield of PE. In contrast, the rate of incidental PE in those undergoing a CT chest scan for non-PE diagnosis remains relatively low and stable. This suggests that our observed increased use of CTPA is clinically appropriate.

Declaration of interest

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

Additional information

Funding

This manuscript was not funded.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.